Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 1 of 6
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`ELI LILLY AND COMPANY,
`
`
`Defendant.
`
`
`
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`
`
`
`
`
`
`JOINT STIPULATION AMENDING PROTECTIVE ORDER
`
`Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc.
`
`(collectively, “Teva”) and Defendant Eli Lilly and Company (“Lilly”) (all together, the “Parties”)
`
`have agreed to enter into this stipulation to amend the Stipulated Protective Order (ECF No. 381)
`
`to facilitate preparation for trial and trial presentation;
`
`WHEREAS, the Parties entered into a Stipulated Protective Order to expedite the flow of
`
`discovery material, facilitate the prompt resolution of any disputes over confidentiality, balance
`
`the Parties’ need for information to conduct this Litigation against their need to maintain the
`
`confidentiality of information entitled to be kept confidential;
`
`WHEREAS, the Parties agree that certain modifications to the confidentiality restrictions
`
`in the Stipulated Protective Order (ECF No. 381) are warranted to permit designated in-house
`
`counsel to participate in trial preparation activities and attend trial; and
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`ELI LILLY AND COMPANY,
`
`
`Defendant.
`
`
`
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`
`
`
`
`
`
`JOINT STIPULATION AMENDING PROTECTIVE ORDER
`
`Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc.
`
`(collectively, “Teva”) and Defendant Eli Lilly and Company (“Lilly”) (all together, the “Parties”)
`
`have agreed to enter into this stipulation to amend the Stipulated Protective Order (ECF No. 381)
`
`to facilitate preparation for trial and trial presentation;
`
`WHEREAS, the Parties entered into a Stipulated Protective Order to expedite the flow of
`
`discovery material, facilitate the prompt resolution of any disputes over confidentiality, balance
`
`the Parties’ need for information to conduct this Litigation against their need to maintain the
`
`confidentiality of information entitled to be kept confidential;
`
`WHEREAS, the Parties agree that certain modifications to the confidentiality restrictions
`
`in the Stipulated Protective Order (ECF No. 381) are warranted to permit designated in-house
`
`counsel to participate in trial preparation activities and attend trial; and
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 2 of 6
`
`WHEREAS, the Stipulated Protective Order (ECF No. 381) provides that the Court may
`
`modify the Protective Order at any time in the interests of justice, and to ensure that any
`
`proceedings before this Court is fair, efficient, and consistent with the public interest
`
`NOW THEREFORE, IT IS HEREBY STIPULATED AND AGREED, by and between
`
`the Parties hereto, and subject to the approval of the Court, the Stipulated Protective Order (ECF
`
`No. 381) is amended as follows:
`
`1.
`
`Material and information designated as “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” pursuant to the Stipulated Protective Order may be disclosed to four (4)
`
`designated In-House Counsel, in accordance with Paragraphs 11 and 12, except that the In-House
`
`Counsel shall not be provided or otherwise possess copies (whether in electronic or paper form)
`
`of any Litigation Material designated “HIGHLY CONFIDENTIAL—OUTSIDE COUNSEL
`
`ONLY.” For clarity, the purpose of this amendment is to permit the Parties’ In-House designees
`
`to participate in trial preparation activities and attend trial when “HIGHLY CONFIDENTIAL—
`
`OUTSIDE COUNSEL ONLY” information is being discussed.
`
`2.
`
`The restrictions in Paragraph 6(b) of the Stipulated Protective Order shall apply to
`
`any In-House Counsel that becomes aware of “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” information under this amendment, unless In-House Counsel has only become
`
`aware of financial information. For the avoidance of doubt, nothing in Paragraph 6(b) shall
`
`preclude In-House Counsel that becomes aware of “HIGHLY CONFIDENTIAL—OUTSIDE
`
`COUNSEL ONLY” information from participating in any prosecution, reexamination, PGR or
`
`IPR proceeding pertaining to fremanezumab, galcanezumab, or any other anti-CGRP antagonist
`
`antibody, provided however, that such In-House Counsel will not amend, draft or otherwise
`
`substantively assist in the drafting or amending of patent claims in any such proceedings.
`
`2
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 3 of 6
`
`3.
`
`A copy of this amendment will be provided to all Third Parties who have produced
`
`information designated “HIGHLY CONFIDENTIAL—OUTSIDE COUNSEL ONLY.”
`
`IT IS SO ORDERED
`
`Dated:
`
`10/14/22
`
`Hon. Allison D. Burroughs
`United States District Judge
`
`3
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 4 of 6
`
`Dated: October 13, 2022
`
`/s/ Elaine Herrmann Blais
`Douglas J. Kline (BBO# 556680)
`Kevin P. Martin (BBO# 655222)
`Elaine Herrmann Blais (BBO# 656142)
`Robert Frederickson III (BBO# 670111)
`Molly Grammel (BBO# 688439)
`Joshua S. Weinger (BBO# 690814)
`Alexandra Lu (BBO# 691114)
`Eric T. Romeo (BBO# 691591)
`Kathleen A. McGuinness (BBO# 693760)
`Tara R. Thigpen (BBO# 707508)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`dkline@goodwinlaw.com
`kmartin@goodwinlaw.com
`eblais@goodwinlaw.com
`rfrederickson@goodwinlaw.com
`mgrammel@goodwinlaw.com
`jweinger@goodwinlaw.com
`alu@goodwinlaw.com
`eromeo@goodwinlaw.com
`kmcguinness@goodwinlaw.com
`tthigpen@goodwinlaw.com
`
`Natasha E. Daughtrey (pro hac vice)
`Sean M. Anderson (pro hac vice)
`GOODWIN PROCTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`Tel.: (213) 426-2500
`Fax: (213) 623-1673
`ndaughtrey@goodwinlaw.com
`sanderson@goodwinlaw.com
`
`
`Respectfully submitted,
`
`s/ Andrea L. Martin (with permission)
`Andrea L. Martin (BBO 666117)
`BURNS & LEVINSON LLP
`125 High Street
`Boston, MA 02110-1624
`(617) 345-3000
`amartin@burnslev.com
`
`Charles E. Lipsey
`Ryan O’Quinn
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`1875 Explorer Street
`Suite 800
`Reston, VA 20190-6023
`Charles.Lipsey@finnegan.com
`Oquinnr@finnegan.com
`
`Emily R. Gabranski (BBO 694417)
`Marta Garcia Daneshvar
`Lulu Wang (BBO 704042)
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`2 Seaport Lane
`Boston, MA 02210-2001
`Emily.Gabranski@finnegan.com
`Marta.Garcia@finnegan.com
`Lulu.Wang@finnegan.com
`
`William B. Raich
`Denise Main
`Danielle A. Duszczyszyn
`Pier D. DeRoo
`Matthew J. Luneack
`Yoonjin Lee
`Sydney Kestle
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`William.Raich@finnegan.com
`Denise.Main@finnegan.com
`Danielle.Duszczyszyn@finnegan.com
`Pier.Deroo@finnegan.com
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 5 of 6
`
`Madeline R. DiLascia (pro hac vice)
`GOODWIN PROCTER LLP
`1900 N Street N.W.
`Washington, D.C. 20036
`Tel.: (202) 346-4000
`Fax: (202) 204-7250
`mdilascia@goodwinlaw.com
`
`Attorneys for Plaintiffs
`
`Matthew.Luneack@finnegan.com
`Yoonjin.Lee@finnegan.com
`Sydney.Kestle@finnegan.com
`
`Attorneys for Defendant Eli Lilly and
`Company
`
`
`
`Case 1:18-cv-12029-ADB Document 528 Filed 10/14/22 Page 6 of 6
`
`CERTIFICATE OF SERVICE
`
`I, Elaine Herrmann Blais, hereby certify that this document filed through the ECF system
`
`will be sent electronically to the registered participants as identified on the Notice of Electronic
`
`Filing (“NEF”) and paper copies will be sent to those indicated as non-registered participants on
`
`October 13, 2022.
`
`
`
`
`/s/ Elaine Herrmann Blais
`Elaine Herrmann Blais (BBO# 656142)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`eblais@goodwinlaw.com
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
